{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:41:08Z","timestamp":1792298468726,"version":"4.4.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s10571-022-01301-9","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T17:05:26Z","timestamp":1666976726000},"page":"1833-1847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review"],"prefix":"10.1007","volume":"43","author":[{"given":"Shubham","family":"Upadhayay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroti","family":"Mundkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gursewak","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.neuropharm.2016.07.003","volume":"113","author":"A Alexander","year":"2017","unstructured":"Alexander A, Irving AJ, Harvey J (2017) Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology 113:652\u2013660. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.003","journal-title":"Neuropharmacology"},{"issue":"6","key":"1301_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mds.28104","volume":"35","author":"A Antonini","year":"2020","unstructured":"Antonini A, Leta V, Teo J, Chaudhuri KR (2020) Outcome of Parkinson\u2019s disease patients affected by COVID-19. Mov Disord 35(6):905\u2013908. https:\/\/doi.org\/10.1002\/mds.28104","journal-title":"Mov Disord"},{"issue":"9","key":"1301_CR3","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak K, Fixemer S, Smaji\u0107 S, Skupin A, Gr\u00fcnewald A (2021) The contribution of microglia to neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22(9):4676. https:\/\/doi.org\/10.3390\/ijms22094676","journal-title":"Int J Mol Sci"},{"key":"1301_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yfrne.2018.09.001","volume":"52","author":"E Baez-Jurado","year":"2019","unstructured":"Baez-Jurado E, Rincon-Benavides MA, Hidalgo-Lanussa O, Guio-Vega G, Ashraf GM, Sahebkar A et al (2019) Molecular mechanisms involved in the protective actions of Selective Estrogen Receptor Modulators in brain cells. Front Neuroendocrinol 52:44\u201364. https:\/\/doi.org\/10.1016\/j.yfrne.2018.09.001","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"1301_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/nmt-2016-0008","volume":"6","author":"SS Baig","year":"2016","unstructured":"Baig SS, Strong M, Quarrell OW (2016) The global prevalence of Huntington\u2019s disease: a systematic review and discussion. Neurodegener Dis Manag 6(4):331\u2013343. https:\/\/doi.org\/10.2217\/nmt-2016-0008","journal-title":"Neurodegener Dis Manag"},{"issue":"20","key":"1301_CR6","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1523\/JNEUROSCI.0434-18.2018","volume":"38","author":"J Barry","year":"2018","unstructured":"Barry J, Akopian G, Cepeda C, Levine MS (2018) Striatal direct and indirect pathway output structures are differentially altered in mouse models of Huntington\u2019s disease. J Neurosci 38(20):4678\u20134694. https:\/\/doi.org\/10.1523\/JNEUROSCI.0434-18.2018","journal-title":"J Neurosci"},{"issue":"1","key":"1301_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR et al (2015) Huntington disease. Nat Rev Dis Primers 1(1):1\u201321. https:\/\/doi.org\/10.1038\/nrdp.2015.5","journal-title":"Nat Rev Dis Primers"},{"issue":"1\u20132","key":"1301_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jneuroim.2009.06.023","volume":"214","author":"E Blasko","year":"2009","unstructured":"Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M et al (2009) Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J Neuroimmunol 214(1\u20132):67\u201377. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.06.023","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1301_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","volume":"34","author":"M Bourque","year":"2013","unstructured":"Bourque M, Morissette M, Cote M, Soulet D, Di Paolo T (2013) Implication of GPER1 in neuroprotection in a mouse model of Parkinson\u2019s disease. Neurobiol Aging 34(3):887\u2013901. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.05.022","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1301_CR10","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.neurobiolaging.2014.03.017","volume":"35","author":"M Bourque","year":"2014","unstructured":"Bourque M, Morissette M, Di Paolo T (2014) Raloxifene activates G protein-coupled estrogen receptor 1\/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Neurobiol Aging 35(10):2347\u20132356. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.017","journal-title":"Neurobiol Aging"},{"key":"1301_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.neuropharm.2015.04.006","volume":"95","author":"M Bourque","year":"2015","unstructured":"Bourque M, Morissette M, Di Paolo T (2015) Neuroprotection in Parkinsonian-treated mice via estrogen receptor alpha activation requires G protein-coupled estrogen receptor 1. Neuropharmacology 95:343\u2013352. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.006","journal-title":"Neuropharmacology"},{"issue":"3","key":"1301_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/STROKEAHA.113.001499","volume":"45","author":"BR Broughton","year":"2014","unstructured":"Broughton BR, Brait VH, Kim HA, Lee S, Chu HX, Gardiner-Mann CV, Arumugam TV (2014) Sex-dependent effects of G protein-coupled estrogen receptor activity on outcome after ischemic stroke. Stroke 45(3):835\u2013841. https:\/\/doi.org\/10.1161\/STROKEAHA.113.001499","journal-title":"Stroke"},{"key":"1301_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119723","volume":"280","author":"M Chahkandi","year":"2021","unstructured":"Chahkandi M, Komeili G, Sepehri G, Khaksari M, Amiresmaili S (2021) Marijuana and beta-estradiol interactions on spatial learning and memory in young female rats: lack of role of the G protein-coupled estrogen receptor (GPR30). Life Sci 280:119723. https:\/\/doi.org\/10.1016\/j.lfs.2021.119723","journal-title":"Life Sci"},{"issue":"2","key":"1301_CR14","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3892\/mmr.2015.3601","volume":"12","author":"J Chen","year":"2015","unstructured":"Chen J, Hu R, Ge H, Duanmu W, Li Y, Xue X et al (2015) G-protein-coupled receptor 30-mediated antiapoptotic effect of estrogen on spinal motor neurons following injury and its underlying mechanisms. Mol Med Rep 12(2):1733\u20131740. https:\/\/doi.org\/10.3892\/mmr.2015.3601","journal-title":"Mol Med Rep"},{"key":"1301_CR15","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20160134","author":"Q Cheng","year":"2016","unstructured":"Cheng Q, Meng J, Wang XS, Kang WB, Tian Z, Zhang K et al (2016) G-1 exerts neuroprotective effects through G protein-coupled estrogen receptor 1 following spinal cord injury in mice. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20160134","journal-title":"Biosci Rep"},{"issue":"2","key":"1301_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12031-016-0856-y","volume":"61","author":"YF Cheng","year":"2017","unstructured":"Cheng YF, Zhu G, Wu QW, Xie YS, Jiang Y, Guo L et al (2017) GPR30 activation contributes to the puerarin-mediated neuroprotection in MPP(+)-induced SH-SY5Y cell death. J Mol Neurosci 61(2):227\u2013234. https:\/\/doi.org\/10.1007\/s12031-016-0856-y","journal-title":"J Mol Neurosci"},{"issue":"4","key":"1301_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biom11040612","volume":"11","author":"FC Church","year":"2021","unstructured":"Church FC (2021) Treatment options for motor and non-motor symptoms of Parkinson\u2019s disease. Biomolecules 11(4):612. https:\/\/doi.org\/10.3390\/biom11040612","journal-title":"Biomolecules"},{"key":"1301_CR18","unstructured":"ClinicalTrials.gov (2015a) Cognitive and neurophysiological effects of raloxifene in Alzheimer's disease. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00065767?term=raloxifene&cond=Neurodegenerative+Disorders&draw=1&rank=2. Accessed 7 September 2022"},{"key":"1301_CR19","unstructured":"ClinicalTrials.gov (2015b) Raloxifene for women with Alzheimer's disease. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00368459?term=raloxifene&cond=Neurodegenerative+Disorders&draw=1&rank=1. Accessed 7 September 2022"},{"issue":"5","key":"1301_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10571-019-00766-5","volume":"40","author":"J Correa","year":"2020","unstructured":"Correa J, Ronchetti S, Labombarda F, De Nicola AF, Pietranera L (2020) Activation of the G protein-coupled estrogen receptor (GPER) increases neurogenesis and ameliorates neuroinflammation in the hippocampus of male spontaneously hypertensive rats. Cell Mol Neurobiol 40(5):711\u2013723. https:\/\/doi.org\/10.1007\/s10571-019-00766-5","journal-title":"Cell Mol Neurobiol"},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2015.05.017","volume":"82","author":"M Cote","year":"2015","unstructured":"Cote M, Bourque M, Poirier AA, Aube B, Morissette M, Di Paolo T, Soulet D (2015) GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson\u2019s disease. Neurobiol Dis 82:99\u2013113. https:\/\/doi.org\/10.1016\/j.nbd.2015.05.017","journal-title":"Neurobiol Dis"},{"issue":"17","key":"1301_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1089\/neu.2013.2854","volume":"30","author":"NL Day","year":"2013","unstructured":"Day NL, Floyd CL, D\u2019Alessandro TL, Hubbard WJ, Chaudry IH (2013) 17Beta-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1. J Neurotrauma 30(17):1531\u20131541. https:\/\/doi.org\/10.1089\/neu.2013.2854","journal-title":"J Neurotrauma"},{"key":"1301_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105989","volume":"214","author":"Z-R Du","year":"2021","unstructured":"Du Z-R, Gu Y, Xie X-M, Zhang M, Jiang G-Y, Chen W-F (2021) GPER and IGF-1R mediate the anti-inflammatory effect of Genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats. J Steroid Biochem Mol Biol 214:105989. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105989","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1301_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-0447.1964.tb05731.x","volume":"40","author":"A Faurbye","year":"1964","unstructured":"Faurbye A, Rasch PJ, Petersen PB, Brandborg G, Pakkenberg H (1964) Neurological symptoms in pharmacotherapy of psychoses. Acta Psychiatr Scand 40(1):10\u201327. https:\/\/doi.org\/10.1111\/j.1600-0447.1964.tb05731.x","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"1301_CR25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","volume":"14","author":"EJ Filardo","year":"2000","unstructured":"Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14(10):1649\u20131660. https:\/\/doi.org\/10.1210\/mend.14.10.0532","journal-title":"Mol Endocrinol"},{"issue":"11","key":"1301_CR26","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(18)30294-1","volume":"17","author":"C Fusilli","year":"2018","unstructured":"Fusilli C, Migliore S, Mazza T, Consoli F, De Luca A, Barbagallo G et al (2018) Biological and clinical manifestations of juvenile Huntington\u2019s disease: a retrospective analysis. Lancet Neurol 17(11):986\u2013993. https:\/\/doi.org\/10.1016\/S1474-4422(18)30294-1","journal-title":"Lancet Neurol"},{"key":"1301_CR27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3389\/fnins.2019.01168","volume":"13","author":"X-Q Gao","year":"2019","unstructured":"Gao X-Q, Du Z-R, Yuan L-J, Zhang W-D, Chen L, Teng J-J et al (2019) Ginsenoside Rg1 exerts anti-inflammatory effects via G protein-coupled estrogen receptor in lipopolysaccharide-induced microglia activation. Front Neurosci 13:1168. https:\/\/doi.org\/10.3389\/fnins.2019.01168","journal-title":"Front Neurosci"},{"issue":"1","key":"1301_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000478908","volume":"24","author":"J Guan","year":"2017","unstructured":"Guan J, Yang B, Fan Y, Zhang J (2017) GPER agonist G1 attenuates neuroinflammation and dopaminergic neurodegeneration in Parkinson disease. NeuroImmunoModulation 24(1):60\u201366. https:\/\/doi.org\/10.1159\/000478908","journal-title":"NeuroImmunoModulation"},{"issue":"15","key":"1301_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2021.711564","volume":"82","author":"C Guo","year":"2021","unstructured":"Guo C, Ma Y-Y (2021) Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders. Front Neural Circuits 82(15):711564. https:\/\/doi.org\/10.3389\/fncir.2021.711564","journal-title":"Front Neural Circuits"},{"issue":"2","key":"1301_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1677\/joe-09-0066","volume":"202","author":"GG Hazell","year":"2009","unstructured":"Hazell GG, Yao ST, Roper JA, Prossnitz ER, O\u2019Carroll AM, Lolait SJ (2009) Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J Endocrinol 202(2):223\u2013236. https:\/\/doi.org\/10.1677\/joe-09-0066","journal-title":"J Endocrinol"},{"issue":"8","key":"1301_CR31","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.biotechadv.2013.08.017","volume":"31","author":"BC Heng","year":"2013","unstructured":"Heng BC, Aubel D, Fussenegger M (2013) An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnol Adv 31(8):1676\u20131694. https:\/\/doi.org\/10.1016\/j.biotechadv.2013.08.017","journal-title":"Biotechnol Adv"},{"issue":"4","key":"1301_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/a:1011119107765","volume":"15","author":"P Heron","year":"2000","unstructured":"Heron P, Daya S (2000) 17\u03b2-Estradiol protects against quinolinic acid-induced lipid peroxidation in the rat brain. Metab Brain Dis 15(4):247\u2013274. https:\/\/doi.org\/10.1023\/a:1011119107765","journal-title":"Metab Brain Dis"},{"issue":"3","key":"1301_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/glia.22445","volume":"61","author":"Y Hirahara","year":"2013","unstructured":"Hirahara Y, Matsuda KI, Yamada H, Saitou A, Morisaki S, Takanami K et al (2013) G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination. Glia 61(3):420\u2013431. https:\/\/doi.org\/10.1002\/glia.22445","journal-title":"Glia"},{"key":"1301_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.coph.2017.02.001","volume":"32","author":"Y Huang","year":"2017","unstructured":"Huang Y, Todd N, Thathiah A (2017) The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention. Curr Opin Pharmacol 32:96\u2013110. https:\/\/doi.org\/10.1016\/j.coph.2017.02.001","journal-title":"Curr Opin Pharmacol"},{"key":"1301_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113699","volume":"419","author":"G Jaiswal","year":"2022","unstructured":"Jaiswal G, Kumar P (2022) Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS\/RNS. Behav Brain Res 419:113699. https:\/\/doi.org\/10.1016\/j.bbr.2021.113699","journal-title":"Behav Brain Res"},{"issue":"8","key":"1301_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1301_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107826","volume":"189","author":"M Jiang","year":"2019","unstructured":"Jiang M, Ma X, Zhao Q, Li Y, Xing Y, Deng Q, Shen Y (2019) The neuroprotective effects of novel estrogen receptor GPER1 in mouse retinal ganglion cell degeneration. Exp Eye Res 189:107826. https:\/\/doi.org\/10.1016\/j.exer.2019.107826","journal-title":"Exp Eye Res"},{"key":"1301_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuroscience.2013.02.005","volume":"238","author":"M Kajta","year":"2013","unstructured":"Kajta M, Rzemieniec J, Litwa E, Lason W, Lenartowicz M, Krzeptowski W, Wojtowicz AK (2013) The key involvement of estrogen receptor beta and G-protein-coupled receptor 30 in the neuroprotective action of Daidzein. Neuroscience 238:345\u2013360. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.02.005","journal-title":"Neuroscience"},{"issue":"6","key":"1301_CR39","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1523-1747.2003.12617.x","volume":"121","author":"N Kanda","year":"2003","unstructured":"Kanda N, Watanabe S (2003) 17\u03b2-Estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J Investig Dermatol 121(6):1500\u20131509. https:\/\/doi.org\/10.1111\/j.1523-1747.2003.12617.x","journal-title":"J Investig Dermatol"},{"issue":"1","key":"1301_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3171\/jns.2003.99.1.0138","volume":"99","author":"HK Kimelberg","year":"2003","unstructured":"Kimelberg HK, Jin Y, Charniga C, Feustel PJ (2003) Neuroprotective activity of tamoxifen in permanent focal ischemia. J Neurosurg 99(1):138\u2013142. https:\/\/doi.org\/10.3171\/jns.2003.99.1.0138","journal-title":"J Neurosurg"},{"key":"1301_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101435","volume":"31","author":"CM Klinge","year":"2020","unstructured":"Klinge CM (2020) Estrogenic control of mitochondrial function. Redox Biol 31:101435. https:\/\/doi.org\/10.1016\/j.redox.2020.101435","journal-title":"Redox Biol"},{"issue":"7","key":"1301_CR42","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/brainsci11070925","volume":"11","author":"MN Krasko","year":"2021","unstructured":"Krasko MN, Hoffmeister JD, Schaen-Heacock NE, Welsch JM, Kelm-Nelson CA, Ciucci MR (2021) Rat models of vocal deficits in Parkinson\u2019s disease. Brain Sci 11(7):925. https:\/\/doi.org\/10.3390\/brainsci11070925","journal-title":"Brain Sci"},{"key":"1301_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jphs.2016.06.005","volume":"3","author":"T Kubota","year":"2016","unstructured":"Kubota T, Matsumoto H, Kirino Y (2016) Ameliorative effect of membrane-associated estrogen receptor G protein coupled receptor 30 activation on object recognition memory in mouse models of Alzheimer\u2019s disease. J Pharmacol Sci 3:219\u2013222. https:\/\/doi.org\/10.1016\/j.jphs.2016.06.005","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"1301_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S (2022) Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol 20(1):158\u2013178. https:\/\/doi.org\/10.2174\/1570159X19666210609160017","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1301_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pharep.2015.07.001","volume":"68","author":"AH Kurt","year":"2016","unstructured":"Kurt AH, Bosnak M, Inan SY, Celik A, Uremis MM (2016) Epileptogenic effects of G protein-coupled estrogen receptor 1 in the rat pentylenetetrazole kindling model of epilepsy. Pharmacol Rep 68(1):66\u201370. https:\/\/doi.org\/10.1016\/j.pharep.2015.07.001","journal-title":"Pharmacol Rep"},{"issue":"3","key":"1301_CR46","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RN Lamptey","year":"2022","unstructured":"Lamptey RN, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23(3):1851. https:\/\/doi.org\/10.3390\/ijms23031851","journal-title":"Int J Mol Sci"},{"key":"1301_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neubiorev.2015.09.024","volume":"67","author":"N Litim","year":"2016","unstructured":"Litim N, Morissette M, Di Paolo T (2016) Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson\u2019s disease. Neurosci Biobehav Rev 67:79\u201388. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.09.024","journal-title":"Neurosci Biobehav Rev"},{"key":"1301_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainresbull.2012.10.004","volume":"93","author":"SB Liu","year":"2013","unstructured":"Liu SB, Zhao MG (2013) Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors. Brain Res Bull 93:27\u201331. https:\/\/doi.org\/10.1016\/j.brainresbull.2012.10.004","journal-title":"Brain Res Bull"},{"issue":"9","key":"1301_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1681.2011.05549.x","volume":"38","author":"SB Liu","year":"2011","unstructured":"Liu SB, Han J, Zhang N, Tian Z, Li XB, Zhao MG (2011) Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor. Clin Exp Pharmacol Physiol 38(9):577\u2013585. https:\/\/doi.org\/10.1111\/j.1440-1681.2011.05549.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"14","key":"1301_CR50","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1523\/JNEUROSCI.5828-11.2012","volume":"32","author":"SB Liu","year":"2012","unstructured":"Liu SB, Zhang N, Guo YY, Zhao R, Shi TY, Feng SF et al (2012) G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci 32(14):4887\u20134900. https:\/\/doi.org\/10.1523\/JNEUROSCI.5828-11.2012","journal-title":"J Neurosci"},{"issue":"2","key":"1301_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbrc.2016.06.044","volume":"477","author":"D Lu","year":"2016","unstructured":"Lu D, Qu Y, Shi F, Feng D, Tao K, Gao G et al (2016) Activation of G protein-coupled estrogen receptor 1 (GPER-1) ameliorates blood\u2013brain barrier permeability after global cerebral ischemia in ovariectomized rats. Biochem Biophys Res Commun 477(2):209\u2013214. https:\/\/doi.org\/10.1016\/j.bbrc.2016.06.044","journal-title":"Biochem Biophys Res Commun"},{"key":"1301_CR52","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s13311-021-01022-9","volume":"2","author":"L Naia","year":"2021","unstructured":"Naia L, Ly P, Mota SI, Lopes C, Maranga C, Coelho P et al (2021) The Sigma-1 receptor mediates pridopidine rescue of mitochondrial function in Huntington Disease models. Neurotherapeutics 2:1017\u20131038. https:\/\/doi.org\/10.1007\/s13311-021-01022-9","journal-title":"Neurotherapeutics"},{"key":"1301_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.579420","volume":"11","author":"G Notas","year":"2020","unstructured":"Notas G, Kampa M, Castanas E (2020) G protein-coupled estrogen receptor in immune cells and its role in immune-related diseases. Front Endocrinol (Lausanne) 11:579420. https:\/\/doi.org\/10.3389\/fendo.2020.579420","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1301_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/405194","volume":"2011","author":"T Numakawa","year":"2011","unstructured":"Numakawa T, Matsumoto T, Numakawa Y, Richards M, Yamawaki S, Kunugi H (2011) Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J Toxicol 2011:405194. https:\/\/doi.org\/10.1155\/2011\/405194","journal-title":"J Toxicol"},{"issue":"1","key":"1301_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.expneurol.2003.09.005","volume":"185","author":"K O'Neill","year":"2004","unstructured":"O\u2019Neill K, Chen S, Brinton RD (2004) Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer\u2019s disease. Exp Neurol 185(1):63\u201380. https:\/\/doi.org\/10.1016\/j.expneurol.2003.09.005","journal-title":"Exp Neurol"},{"issue":"3","key":"1301_CR56","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G (2020) BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci 21(3):1170. https:\/\/doi.org\/10.3390\/ijms21031170","journal-title":"Int J Mol Sci"},{"key":"1301_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbi.2020.04.005","volume":"88","author":"M-X Pan","year":"2020","unstructured":"Pan M-X, Li J, Ma C, Fu K, Li Z-Q, Wang Z-F (2020) Sex-dependent effects of GPER activation on neuroinflammation in a rat model of traumatic brain injury. Brain Behav Immun 88:421\u2013431. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.005","journal-title":"Brain Behav Immun"},{"key":"1301_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113008","volume":"320","author":"J Peng","year":"2019","unstructured":"Peng J, Zuo Y, Huang L, Okada T, Liu S, Zuo G et al (2019) Activation of GPR30 with G1 attenuates neuronal apoptosis via src\/EGFR\/stat3 signaling pathway after subarachnoid hemorrhage in male rats. Exp Neurol 320:113008. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113008","journal-title":"Exp Neurol"},{"key":"1301_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2016.08.004","volume":"48","author":"AA Poirier","year":"2016","unstructured":"Poirier AA, Cote M, Bourque M, Morissette M, Di Paolo T, Soulet D (2016) Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson\u2019s disease. Neurobiol Aging 48:61\u201371. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.004","journal-title":"Neurobiol Aging"},{"key":"1301_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105261","volume":"146","author":"FH Pottoo","year":"2020","unstructured":"Pottoo FH, Tabassum N, Javed MN, Nigar S, Sharma S, Barkat MA et al (2020) Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice. Eur J Pharm Sci 146:105261. https:\/\/doi.org\/10.1016\/j.ejps.2020.105261","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"1301_CR61","doi-asserted-by":"publisher","first-page":"e3001279","DOI":"10.1371\/journal.pbio.3001279","volume":"19","author":"M Proietti Onori","year":"2021","unstructured":"Proietti Onori M, Koene LMC, Schafer CB, Nellist M, de Brito van Velze M, Gao Z et al (2021) RHEB\/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity. PLoS Biol 19(5):e3001279. https:\/\/doi.org\/10.1371\/journal.pbio.3001279","journal-title":"PLoS Biol"},{"issue":"3\u20135","key":"1301_CR62","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jsbmb.2008.03.006","volume":"109","author":"ER Prossnitz","year":"2008","unstructured":"Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB (2008) The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol 109(3\u20135):350\u2013353. https:\/\/doi.org\/10.1016\/j.jsbmb.2008.03.006","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"1301_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0028-3886.226451","volume":"66","author":"DM Radhakrishnan","year":"2018","unstructured":"Radhakrishnan DM, Goyal V (2018) Parkinson\u2019s disease: a review. Neurology (India) 66(7):26\u201335. https:\/\/doi.org\/10.4103\/0028-3886.226451","journal-title":"Neurology (India)"},{"issue":"12","key":"1301_CR64","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.4103\/1673-5374.262577","volume":"14","author":"C Roque","year":"2019","unstructured":"Roque C, Baltazar G (2019) G protein-coupled estrogen receptor 1 (GPER) activation triggers different signaling pathways on neurons and astrocytes. Neural Regen Res 14(12):2069\u20132070. https:\/\/doi.org\/10.4103\/1673-5374.262577","journal-title":"Neural Regen Res"},{"key":"1301_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2019.100786","volume":"55","author":"C Roque","year":"2019","unstructured":"Roque C, Mendes-Oliveira J, Duarte-Chendo C, Baltazar G (2019) The role of G protein-coupled estrogen receptor 1 on neurological disorders. Front Neuroendocrinol 55:100786. https:\/\/doi.org\/10.1016\/j.yfrne.2019.100786","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"1301_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12837","volume":"32","author":"E Sarchielli","year":"2020","unstructured":"Sarchielli E, Guarnieri G, Idrizaj E, Squecco R, Mello T, Comeglio P et al (2020) The G protein-coupled oestrogen receptor, GPER1, mediates direct anti-inflammatory effects of oestrogens in human cholinergic neurones from the nucleus basalis of Meynert. J Neuroendocrinol 32(3):e12837. https:\/\/doi.org\/10.1111\/jne.12837","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"1301_CR67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/s0011-5029(03)00065-8","volume":"49","author":"BF Shneker","year":"2003","unstructured":"Shneker BF, Fountain NB (2003) Epilepsy. Dis Mon 49(7):426\u2013478. https:\/\/doi.org\/10.1016\/s0011-5029(03)00065-8","journal-title":"Dis Mon"},{"issue":"1","key":"1301_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11011-011-9266-6","volume":"27","author":"S Subramanian","year":"2012","unstructured":"Subramanian S, Miller LM, Grafe MR, Vandenbark AA, Offner H (2012) Contribution of GPR30 for 1, 25 dihydroxyvitamin D3 protection in EAE. Metab Brain Dis 27(1):29\u201335. https:\/\/doi.org\/10.1007\/s11011-011-9266-6","journal-title":"Metab Brain Dis"},{"issue":"10","key":"1301_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16(10):529\u2013546. https:\/\/doi.org\/10.1038\/s41582-020-0389-4","journal-title":"Nat Rev Neurol"},{"issue":"1\u20132","key":"1301_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mce.2014.01.024","volume":"387","author":"H Tang","year":"2014","unstructured":"Tang H, Zhang Q, Yang L, Dong Y, Khan M, Yang F et al (2014a) GPR30 mediates estrogen rapid signaling and neuroprotection. Mol Cell Endocrinol 387(1\u20132):52\u201358. https:\/\/doi.org\/10.1016\/j.mce.2014.01.024","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"1301_CR71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mce.2014.05.005","volume":"389","author":"H Tang","year":"2014","unstructured":"Tang H, Zhang Q, Yang L, Dong Y, Khan M, Yang F et al (2014b) Reprint of \u201cGPR30 mediates estrogen rapid signaling and neuroprotection.\u201d Mol Cell Endocrinol 389(1\u20132):92\u201398. https:\/\/doi.org\/10.1016\/j.mce.2014.05.005","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"1301_CR72","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.psyneuen.2013.04.011","volume":"38","author":"Z Tian","year":"2013","unstructured":"Tian Z, Wang Y, Zhang N, Guo Y-Y, Feng B, Liu S-B, Zhao M-G (2013) Estrogen receptor GPR30 exerts anxiolytic effects by maintaining the balance between GABAergic and glutamatergic transmission in the basolateral amygdala of ovariectomized mice after stress. Psychoneuroendocrinology 38(10):2218\u20132233. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.04.011","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"1301_CR73","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/070674370004500310","volume":"45","author":"P Turrone","year":"2000","unstructured":"Turrone P, Seeman MV, Silvestri S (2000) Estrogen receptor activation and tardive dyskinesia. Can J Psychiatry 45(3):288\u2013290. https:\/\/doi.org\/10.1177\/070674370004500310","journal-title":"Can J Psychiatry"},{"issue":"8","key":"1301_CR74","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/j.jmb.2019.11.012","volume":"432","author":"E Valionyte","year":"2020","unstructured":"Valionyte E, Yang Y, Roberts SL, Kelly J, Lu B, Luo S (2020) Lowering mutant huntingtin levels and toxicity: autophagy-endolysosome pathways in Huntington\u2019s disease. J Mol Biol 432(8):2673\u20132691. https:\/\/doi.org\/10.1016\/j.jmb.2019.11.012","journal-title":"J Mol Biol"},{"key":"1301_CR75","doi-asserted-by":"publisher","DOI":"10.7916\/d88p5z71","author":"O Waln","year":"2013","unstructured":"Waln O, Jankovic J (2013) An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (NY). https:\/\/doi.org\/10.7916\/d88p5z71","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"issue":"4","key":"1301_CR76","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.bbrc.2016.11.138","volume":"482","author":"ZF Wang","year":"2017","unstructured":"Wang ZF, Pan ZY, Xu CS, Li ZQ (2017) Activation of G-protein coupled estrogen receptor 1 improves early-onset cognitive impairment via PI3K\/Akt pathway in rats with traumatic brain injury. Biochem Biophys Res Commun 482(4):948\u2013953. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.138","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1301_CR77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/glia.23697","volume":"68","author":"XS Wang","year":"2020","unstructured":"Wang XS, Yue J, Hu LN, Tian Z, Zhang K, Yang L et al (2020) Activation of G protein-coupled receptor 30 protects neurons by regulating autophagy in astrocytes. Glia 68(1):27\u201343. https:\/\/doi.org\/10.1002\/glia.23697","journal-title":"Glia"},{"issue":"2","key":"1301_CR78","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/bpa.12925","volume":"31","author":"Z Wang","year":"2021","unstructured":"Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R et al (2021) Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18F-FDG PET\u2013CT values. Brain Pathol 31(2):346\u2013364. https:\/\/doi.org\/10.1111\/bpa.12925","journal-title":"Brain Pathol"},{"issue":"2","key":"1301_CR79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40120-018-0105-0","volume":"7","author":"KM Ward","year":"2018","unstructured":"Ward KM, Citrome L (2018) Antipsychotic-related movement disorders: drug-induced Parkinsonism vs. tardive dyskinesia\u2014key differences in pathophysiology and clinical management. Neurol Ther 7(2):233\u2013248. https:\/\/doi.org\/10.1007\/s40120-018-0105-0","journal-title":"Neurol Ther"},{"issue":"4","key":"1301_CR80","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.3892\/mmr.2018.8618","volume":"17","author":"Y Wu","year":"2018","unstructured":"Wu Y, Feng D, Lin J, Qu Y, He S, Wang Y et al (2018) Downregulation of G-protein coupled receptor 30 in the hippocampus attenuates the neuroprotection of estrogen in the critical period hypothesis. Mol Med Rep 17(4):5716\u20135725. https:\/\/doi.org\/10.3892\/mmr.2018.8618","journal-title":"Mol Med Rep"},{"key":"1301_CR81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresbull.2021.04.005","volume":"172","author":"LK Yang","year":"2021","unstructured":"Yang LK, Lu L, Yue J, Wang XS, Qi JY, Yang F, Liu SB (2021) Activation of microglial G-protein-coupled receptor 30 protects neurons against excitotoxicity through NF-kappaB\/MAPK pathways. Brain Res Bull 172:22\u201330. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.04.005","journal-title":"Brain Res Bull"},{"issue":"1","key":"1301_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2172-11-20","volume":"11","author":"MA Yates","year":"2010","unstructured":"Yates MA, Li Y, Chlebeck PJ, Offner H (2010) GPR30, but not estrogen receptor-\u03b1, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol 11(1):11\u201320. https:\/\/doi.org\/10.1186\/1471-2172-11-20","journal-title":"BMC Immunol"},{"key":"1301_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2019.100788","volume":"55","author":"C Yilmaz","year":"2019","unstructured":"Yilmaz C, Karali K, Fodelianaki G, Gravanis A, Chavakis T, Charalampopoulos I, Alexaki VI (2019) Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol 55:100788. https:\/\/doi.org\/10.1016\/j.yfrne.2019.100788","journal-title":"Front Neuroendocrinol"},{"key":"1301_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105384","volume":"192","author":"LJ Yuan","year":"2019","unstructured":"Yuan LJ, Wang XW, Wang HT, Zhang M, Sun JW, Chen WF (2019) G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP\/MPP(+)-induced dopaminergic neuronal injury. J Steroid Biochem Mol Biol 192:105384. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105384","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"1301_CR85","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1021\/acschemneuro.9b00287","volume":"10","author":"J Yue","year":"2019","unstructured":"Yue J, Wang XS, Feng B, Hu LN, Yang LK, Lu L et al (2019) Activation of G-protein-coupled receptor 30 protects neurons against excitotoxicity through inhibiting excessive autophagy induced by glutamate. ACS Chem Neurosci 10(10):4227\u20134236. https:\/\/doi.org\/10.1021\/acschemneuro.9b00287","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1301_CR86","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-018-1246-x","volume":"15","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Qin P, Deng Y, Ma Z, Guo H, Guo H et al (2018) The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation. J Neuroinflamm 15(1):206. https:\/\/doi.org\/10.1186\/s12974-018-1246-x","journal-title":"J Neuroinflamm"},{"issue":"8","key":"1301_CR87","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s11064-021-03336-8","volume":"46","author":"X Zhang","year":"2021","unstructured":"Zhang X, Yang Y, Guo L, Zhou J, Niu J, Wang P et al (2021) GPER1 modulates synaptic plasticity during the development of temporal lobe epilepsy in rats. Neurochem Res 46(8):2019\u20132032. https:\/\/doi.org\/10.1007\/s11064-021-03336-8","journal-title":"Neurochem Res"},{"issue":"4","key":"1301_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.449","volume":"6","author":"TZ Zhao","year":"2016","unstructured":"Zhao TZ, Ding Q, Hu J, He SM, Shi F, Ma LT (2016) GPER expressed on microglia mediates the anti-inflammatory effect of estradiol in ischemic stroke. Brain Behav 6(4):e00449. https:\/\/doi.org\/10.1002\/brb3.449","journal-title":"Brain Behav"},{"key":"1301_CR89","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.brainresbull.2018.05.017","volume":"140","author":"F Zhou","year":"2018","unstructured":"Zhou F, Dong H, Liu Y, Yan L, Sun C, Hao P et al (2018) Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis. Brain Res Bull 140:281\u2013290. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.05.017","journal-title":"Brain Res Bull"},{"key":"1301_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.134978","volume":"728","author":"D Zuo","year":"2020","unstructured":"Zuo D, Wang F, Rong W, Wen Y, Sun K, Zhao X et al (2020) The novel estrogen receptor GPER1 decreases epilepsy severity and susceptivity in the hippocampus after status epilepticus. Neurosci Lett 728:134978. https:\/\/doi.org\/10.1016\/j.neulet.2020.134978","journal-title":"Neurosci Lett"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-022-01301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-022-01301-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-022-01301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T06:30:21Z","timestamp":1687501821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-022-01301-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s10571-022-01301-9","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"23 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest being it financial or contractual with regard to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}